Infectocipro (Ciprofloxacin Hydrochloride Monohydrate)

Infectocipro is a fluoroquinolone antibiotic indicated for bacterial ear conditions. It is applied directly to the external auditory canal to eradicate pathogens.

• Otitis externa: reduces bacterial load and alleviates inflammation in the outer ear canal.
• Acute bacterial ear canal infection: provides rapid antibacterial activity to control infection.
• Chronic otitis externa: helps eradicate resistant organisms and prevent recurrence.

• Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By blocking these targets, the drug prevents bacterial cell division and leads to bacterial cell death, delivering a bactericidal effect against susceptible gram‑negative and gram‑positive organisms in the ear canal.

Common Side Effects

• Ear irritation: mild burning or stinging sensation at the application site.
• Itching: localized pruritus within the ear canal.
• Temporary hearing changes: transient muffled hearing after dosing.
• Redness: mild erythema of the external ear.
• Discharge: watery or serous ear fluid.
• Local pain: mild discomfort during or after application.

Serious or Rare Side Effects

• Allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention.
• Ototoxicity: potential hearing loss or vestibular dysfunction with extensive exposure.
• Severe vestibular disturbance: dizziness or vertigo.
• Stevens‑Johnson syndrome: rare severe skin reaction.
• Tendon rupture: systemic exposure may increase risk of tendon injury.
• Severe local infection: worsening of ear infection despite therapy.

Infectocipro should be used with caution and according to professional guidance.

• Allergy assessment: avoid if the patient has known hypersensitivity to fluoroquinolones.
• Ear condition: confirm an intact tympanic membrane before administration.
• Age considerations: use carefully in pediatric patients; dosage may differ.
• Concurrent ototoxic drugs: monitor for additive ear toxicity when used with other ototoxic agents.
• Pregnancy and lactation: consult a healthcare professional before use.
• Store at below 25°C: keep in the original container, protect from moisture and light.

Infectocipro may interact with other medicines; monitoring is advised.

Major Interactions (Avoid)

• Systemic fluoroquinolones: concurrent use can increase risk of systemic toxicity.
• Corticosteroid ear drops: may heighten local irritation.
• Antacids containing aluminum or magnesium: can reduce systemic absorption if systemic exposure occurs.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory drugs: monitor for tendon injury risk.
• Warfarin: observe INR values if systemic absorption is suspected.
• Diabetes medications: watch for altered blood glucose control.